CVS Health (CVS) November weekly option implied volatility elevated into EPS and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
November 7, 2019 6:55 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $71.00 price target on CVS Health (NYSE: CVS) following the company's 3Q earnings report. CVS reported 3Q:19 EPS of $1.84, above consensus of $1.76. Adjusted operating profit was $3.947bn versus consensus at $3.89bn.
The tone of... More
